Conditions: Pulmonary Fibrosis
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 20
Healthy volunteers: no

Brief summary:
Primary objective of this study is to investigate the long-term tolerability and safety profile of BIBF 1120 on top of pirfenidone treatment in patients with Idiopathic Pulmonary Fibrosis who have completed a prior clinical trial of BIBF 1120 (1199.31).

Secondary objectives are to assess effects on some efficacy criteria during long term treatment with BIBF 1120 on top of pirfenidone.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: Nintedanib intervention 2: Pirfenidoneone
Intervention descriptions: intervention 1: 150 mg bid intervention 2: Existing treatment

Protocol document: